Medical Research News

RSS

12-HETE enzyme inhibition can prevent ischemic retinopathy: Study

The inhibition or removal of an enzyme may prevent or treat ischemic retinopathy by stalling growth of unwanted vessels in the retina, Medical College of Georgia researchers say.

14 Jan 2011

Bill and Melinda Gates Foundation grants $1.5million to Liverpool University for bacterial study

A University of Liverpool-led consortium has received $1.5million from the Bill & Melinda Gates Foundation to study a bacterium that causes serious disease and epidemics in sub-Saharan Africa.

14 Jan 2011

20% of cancer survivors experience chronic pain: Study

Surviving cancer may also mean surviving pain, according to a study by the University of Michigan Health System showing 20 percent of cancer survivors at least two years post diagnosis have current cancer-related chronic pain.

13 Jan 2011

New research shows enzyme-armed oncolytic virus may help fight brain tumors

New research shows that oncolytic viruses, which are engineered to destroy cancer cells, might be more effective in treating deadly brain tumors if equipped with an enzyme that helps them penetrate the tumor.

13 Jan 2011

Combination therapy initially, best for blood pressure control: ACCELERATE study

A new study published online Jan. 13 in The Lancet shows that patients with high blood pressure respond better to a combination drug therapy than those on monotherapy. Also patients who undergo the two-drug treatment after taking the single-drug therapy also experience better blood pressure outcomes, though not at the same level as those who began with the combination treatment, according to research.

13 Jan 2011

Good cholesterol efficiency more important than quantity: Study

According to a new study the amount of good cholesterol a person has is not as important as how well that good cholesterol works to stop heart disease. Good cholesterol or High-Density Lipoprotein—also known as HDL is known to be healthy for the heart with people having high blood levels of HDL being at a lower risk of developing heart disease than people with low levels.

13 Jan 2011

LUMEDX announces CD on analytical software for investigating lab utilization in cardiovascular service lines

LUMEDX Corporation, a leading provider of vendor-neutral, integrated medical imaging and information systems, announced a new complimentary Webinar on CD, The Power of Analytics: Lab Utilization. The Webinar shows viewers how to use analytical software to investigate lab utilization in their cardiovascular service lines.

13 Jan 2011

Exposure to room light prior to bedtime suppresses melatonin levels, increases cancer and diabetes risk: Study

According to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism, exposure to electrical light between dusk and bedtime strongly suppresses melatonin levels and may impact physiologic processes regulated by melatonin signaling, such as sleepiness, thermoregulation, blood pressure and glucose homeostasis.

13 Jan 2011

Sanofi-aventis, UCSF announce research and development collaborations

Sanofi-aventis and the University of California, San Francisco (UCSF) announced today that they have formed two research and development collaborations that join together leaders from academia and industry to more rapidly advance groundbreaking innovation from the lab to the patient.

13 Jan 2011

Pan-European comparative genomics project to develop software suite for gene regulation analysis

Today, CLC bio announced to be heading a pan-European comparative genomics project, COGANGS (Comparative Genomics and Next Generation Sequencing), to develop a software suite, where up to one thousand genomes, can be used as knowledge input in gene regulation analysis.

13 Jan 2011

The past, present and future of anthrax research

Few strands of bacteria have achieved such a central place in public consciousness as Bacillus anthracis, the bacteria which causes Anthrax. While today it is a feared weapon of bioterrorism Bacillus anthracis has played a significant historical role, especially through the research of the celebrated 19th century scientists Robert Koch and Louis Pasteur, in shaping our understanding of infectious diseases and immunology

13 Jan 2011

Addition of caffeine to alcohol does not improve sustained attention or reaction times

Marketing efforts that encourage mixing caffeinated "energy" drinks with alcohol often try to sway young people to believe that caffeine will offset the sedating effects of alcohol and increase alertness and stamina.

13 Jan 2011

Antibiotics need to be used only when diagnosis of acute ear infection is certain

A new study showed that antibiotics are more effective than previously thought in the treatment of acute ear infection (namely acute otitis media) in young children. However, half of the children became better without antibiotics. Expectedly, antibiotics caused more adverse events. Antibiotics should be used only when the diagnosis of acute ear infection is certain.

13 Jan 2011

Scientists demonstrate how one gene evolves two competing functions via duplication

Researchers report that they are the first to show in molecular detail how one gene evolved two competing functions that eventually split up - via gene duplication - to pursue their separate destinies.

13 Jan 2011

BP-lowering medications provide long-term benefit of reducing death risk from cardiovascular disease

In a study published in December 2010, in Hypertension, a journal of the American Heart Association, investigators have shown that early treatment with blood pressure-lowering medications provides a long-term benefit of reducing the risk of death from cardiovascular disease.

13 Jan 2011

Largest long-term examination of children's health and development in the US

The National Children's Study (NCS) has begun inviting women in San Diego to participate in the largest long-term examination of children's health and development ever conducted in the United States.

13 Jan 2011

SRI International receives $17.4 million grant to boost treatments for cardiovascular, lung, blood diseases

SRI International, an independent nonprofit research and development organization, announced today that it has been awarded two preclinical services contracts totaling $17.4 million by the National Heart, Lung, and Blood Institute, one of the National Institutes of Health.

13 Jan 2011

Transition of oncology programme into lead optimisation triggers EUR 2.0M milestone payment to Evotec

Evotec AG today announced that its research alliance with Boehringer Ingelheim has reached a milestone triggering a payment of EUR 2.0 million to Evotec.

13 Jan 2011

DNAVision purchases 4 of Life Technologies' NGS platforms

DNAVision, one of European leading genetic analysis service providers, is pleased to announce the purchase of four next-generation sequencing platforms from Life Technologies, including two latest 5500xl SOLiD™ Systems.

13 Jan 2011

Antibiotic treatment may be sufficient to overcome River Blindness

The team found that a bacterium inside the worm acts as a 'disguise' for the parasite, resulting in the immune system reacting to it in an ineffective way. The bacteria protect the worm from the body's natural defences, but once the bacteria are removed with antibiotics, the immune system responds appropriately, releasing cells, called eosinophils, that kill the worm.

13 Jan 2011

Medical Research News

12-HETE enzyme inhibition can prevent ischemic retinopathy: Study

Bill and Melinda Gates Foundation grants $1.5million to Liverpool University for bacterial study

20% of cancer survivors experience chronic pain: Study

New research shows enzyme-armed oncolytic virus may help fight brain tumors

Combination therapy initially, best for blood pressure control: ACCELERATE study

Good cholesterol efficiency more important than quantity: Study

LUMEDX announces CD on analytical software for investigating lab utilization in cardiovascular service lines

Exposure to room light prior to bedtime suppresses melatonin levels, increases cancer and diabetes risk: Study

Sanofi-aventis, UCSF announce research and development collaborations

Pan-European comparative genomics project to develop software suite for gene regulation analysis

The past, present and future of anthrax research

Addition of caffeine to alcohol does not improve sustained attention or reaction times

Antibiotics need to be used only when diagnosis of acute ear infection is certain

Scientists demonstrate how one gene evolves two competing functions via duplication

BP-lowering medications provide long-term benefit of reducing death risk from cardiovascular disease

Largest long-term examination of children's health and development in the US

SRI International receives $17.4 million grant to boost treatments for cardiovascular, lung, blood diseases

Transition of oncology programme into lead optimisation triggers EUR 2.0M milestone payment to Evotec

DNAVision purchases 4 of Life Technologies' NGS platforms

Antibiotic treatment may be sufficient to overcome River Blindness

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News